Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration.

This article focuses on evaluating the physical compatibility of remimazolam, an ultra–short-acting benzodiazepine intravenous anesthetic, when combined with opioid analgesics, muscle relaxants, and sedatives during simulated Y-site administration. The study tested remimazolam admixed with remifentanil, fentanyl, rocuronium, vecuronium, dexmedetomidine, and midazolam using visual inspection, turbidity measurement, and pH assessment immediately and up to 4 hours after mixing. Results indicated no physical incompatibilities in any two- or three-drug combinations tested, with all mixtures remaining clear and stable within clinically relevant concentrations. These findings provide evidence supporting the co-administration of remimazolam with these drugs via the same intravenous line for up to 4 hours, although the study did not assess chemical stability or longer-term compatibility.